Literature DB >> 17077276

Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/- mice.

Isabelle M Frey1, Isabel Rubio-Aliaga, Anne Siewert, Daniela Sailer, Aleksey Drobyshev, Johannes Beckers, Martin Hrabé de Angelis, Julie Aubert, Avner Bar Hen, Oliver Fiehn, Hans M Eichinger, Hannelore Daniel.   

Abstract

PEPT2 is an integral membrane protein in the apical membrane of renal epithelial cells that operates as a rheogenic transporter for di- and tripeptides and structurally related drugs. Its prime role is thought to be the reabsorption of filtered di- and tripeptides contributing to amino acid homeostasis. To elucidate the role of PEPT2 in renal amino acid metabolism we submitted kidney tissues of wild-type and a Pept2(-/-) mouse line to a comprehensive transcriptome, proteome and metabolome profiling and analyzed urinary amino acids and dipeptides. cDNA microarray analysis identified 147 differentially expressed transcripts in transporter-deficient animals, and proteome analysis by 2D-PAGE and MALDI-TOF-MS identified 37 differentially expressed proteins. Metabolite profiling by GC-MS revealed predominantly altered concentrations of amino acids and derivatives. Urinary excretion of amino acids demonstrated increased glycine and cysteine/cystine concentrations and dipeptides in urine were assessed by amino acid analysis of urine samples before and after in vitro dipeptidase digestion. Dipeptides constituted a noticeable fraction of urinary amino acids in Pept2(-/-) animals, only, and dipeptide-bound glycine and cystine were selectively increased in Pept2(-/-) urine samples. These findings were confirmed by a drastically increased excretion of cysteinyl-glycine (cys-gly). Urinary loss of cys-gly together with lower concentrations of cysteine, glycine, and oxoproline in kidney tissue and altered expression of mRNA and proteins involved in glutathione (GSH) metabolism suggests that PEPT2 is predominantly a system for reabsorption of cys-gly originating from GSH break-down, thus contributing to resynthesis of GSH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077276     DOI: 10.1152/physiolgenomics.00193.2006

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  16 in total

1.  Transcriptional and metabolic data integration and modeling for identification of active pathways.

Authors:  Alexandra Jauhiainen; Olle Nerman; George Michailidis; Rebecka Jörnsten
Journal:  Biostatistics       Date:  2012-06-14       Impact factor: 5.899

Review 2.  The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.

Authors:  Stephanie Cherqui; Pierre J Courtoy
Journal:  Nat Rev Nephrol       Date:  2016-12-19       Impact factor: 28.314

3.  Cysteinyl-glycine in the control of glutathione homeostasis in bovine lenses.

Authors:  Gian Marco De Donatis; Roberta Moschini; Mario Cappiello; Antonella Del Corso; Umberto Mura
Journal:  Mol Vis       Date:  2010-06-05       Impact factor: 2.367

4.  Drug off-target effects predicted using structural analysis in the context of a metabolic network model.

Authors:  Roger L Chang; Li Xie; Lei Xie; Philip E Bourne; Bernhard Ø Palsson
Journal:  PLoS Comput Biol       Date:  2010-09-23       Impact factor: 4.475

5.  Metabolomic and transcriptomic analysis of the rice response to the bacterial blight pathogen Xanthomonas oryzae pv. oryzae.

Authors:  Theodore R Sana; Steve Fischer; Gert Wohlgemuth; Anjali Katrekar; Ki-Hong Jung; Pam C Ronald; Oliver Fiehn
Journal:  Metabolomics       Date:  2010-05-27       Impact factor: 4.290

Review 6.  Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology.

Authors:  Nazzareno Ballatori; Suzanne M Krance; Rosemarie Marchan; Christine L Hammond
Journal:  Mol Aspects Med       Date:  2008-08-26

Review 7.  Towards better mouse models: enhanced genotypes, systemic phenotyping and envirotype modelling.

Authors:  Johannes Beckers; Wolfgang Wurst; Martin Hrabé de Angelis
Journal:  Nat Rev Genet       Date:  2009-06       Impact factor: 53.242

Review 8.  Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.

Authors:  David E Smith; Benjamin Clémençon; Matthias A Hediger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

9.  The challenges for molecular nutrition research 3: comparative nutrigenomics research as a basis for entering the systems level.

Authors:  Hannelore Daniel; Christian A Drevon; Ulla I Klein; Robert Kleemann; Ben van Ommen
Journal:  Genes Nutr       Date:  2008-10-01       Impact factor: 5.523

Review 10.  Emerging regulatory paradigms in glutathione metabolism.

Authors:  Yilin Liu; Annastasia S Hyde; Melanie A Simpson; Joseph J Barycki
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.